Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2014 2
2015 4
2016 3
2017 1
2018 1
2019 1
2020 6
2021 6
2022 8
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Perceptions of patent and proprietary medicine vendors and communities of the tiered accreditation programme for family planning services in Lagos and Kaduna states, Nigeria.
Igbokwe U, Baba-Ari AW, Igomu B, Okafor E, Musa I, Peters O, Okafor U, Molemodile Dele-Olowu S, Olalere E, Aigbogun E Jr, Aina M. Igbokwe U, et al. Among authors: musa i. Glob Public Health. 2023 Jan;18(1):2230488. doi: 10.1080/17441692.2023.2230488. Glob Public Health. 2023. PMID: 37417453 Free article.
An insight into the mechanisms of action of selected bioactive compounds against epigenetic targets of prostate cancer: implications on histones modifications.
Katsayal BS, Forcados GE, Yusuf AP, Lawal YA, Jibril SA, Nuraddeen H, Ibrahim MM, Sadiq IZ, Abubakar MB, Malami I, Abubakar IB, Muhammad A. Katsayal BS, et al. Among authors: ibrahim mm. In Silico Pharmacol. 2023 Apr 15;11(1):10. doi: 10.1007/s40203-023-00148-2. eCollection 2023. In Silico Pharmacol. 2023. PMID: 37073308 Free PMC article.
Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation.
Yang N, Maskey AR, Srivastava K, Kim M, Wang Z, Musa I, Shi Y, Gong Y, Fidan O, Wang J, Dunkin D, Chung D, Zhan J, Miao M, Sampson HA, Li XM. Yang N, et al. Among authors: musa i. Front Immunol. 2023 Feb 7;14:1081121. doi: 10.3389/fimmu.2023.1081121. eCollection 2023. Front Immunol. 2023. PMID: 36825019 Free PMC article.
Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid.
Li K, Yu XH, Maskey AR, Musa I, Wang ZZ, Garcia V, Guo A, Yang N, Srivastava K, Dunkin D, Li JX, Guo L, Cheng YC, Yuan H, Tiwari R, Li XM. Li K, et al. Among authors: musa i. Front Pharmacol. 2023 Jan 30;13:1042756. doi: 10.3389/fphar.2022.1042756. eCollection 2022. Front Pharmacol. 2023. PMID: 36793921 Free PMC article.
38 results